Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid ArthritisJing Cui, Dorothee Diogo, Eli A Stahl, et al.
Annals of the Rheumatic Diseases|March 29, 2023
EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and bordersJonas Jw Kuiper, Jörg C Prinz, Efstratios Stratikos, et al.
Annals of the Rheumatic Diseases|December 13, 2012
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritisMaša Umiċeviċ Mirkov, Jing Cui, Sita H Vermeulen, et al.
Arthritis and Rheumatism|March 24, 2010
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapyJing Cui, Saedis Saevarsdottir, Brian Thomson, et al.
Nature Genetics|September 17, 2008
Common variants at CD40 and other loci confer risk of rheumatoid arthritisSoumya Raychaudhuri, Elaine F Remmers, Annette T Lee, et al.
Plos One|February 13, 2014
Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk geneYukinori Okada, Dorothee Diogo, Jeffrey D Greenberg, et al.
Plos Medicine|October 30, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortiumSigne Hässler, Delphine Bachelet, Julianne Duhaze, et al.
Plos One|April 8, 2015
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traitsDorothée Diogo, Lisa Bastarache, Katherine P Liao, et al.
Plos Genetics|April 5, 2013
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritisJing Cui, Eli A Stahl, Saedis Saevarsdottir, et al.
Nature Genetics|November 10, 2009
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis riskSoumya Raychaudhuri, Brian P Thomson, Elaine F Remmers, et al.
Pageof 8